Open AccessFinancial Leadership at Lonza
Author(s) -
Rodolfo J. Savitzky,
Klaus Möller
Publication year - 2021
Publication title -
controlling
Language(s) - English
Resource type - Journals
ISSN - 0935-0381
DOI - 10.15358/0935-0381-2021-1-75
Subject(s) - business , biocide , commerce , finance , chemistry , organic chemistry
Lonza Group AG, based in Basel, Switzerland, manufactures active pharmaceutical ingredients, biotechnology products organic, fine chemicals and biocides. The Company offers custom chemical manufacturing and fermentation processing and manufactures its products for the life sciences, pharmaceuticals, food processing, and agricultural industries. Founded in 1897 Lonza has grown into a global chemicals and biotechnology business. The Company operates on 120 sites and offices in more than 35 countries with 15,500 full-time employees. In 2019, Lonza generated sales of CHF 5.9 bn with a CORE EBITDA of CHF 1.6 bn.